| Association of severe lymphopenia and disease progression in unresectable locally advanced non-small cell lung cancer treated with definitive chemoradiation and immunotherapy C Friedes, T Chakrabarti, S Olson, L Prichett, JR Brahmer, PM Forde, ... Lung Cancer 154, 36-43, 2021 | 46 | 2021 |
| Longitudinal trends of financial toxicity in patients with lung cancer: a prospective cohort study C Friedes, SZ Hazell, W Fu, C Hu, RK Voong, B Lee, JL Feliciano, ... JCO oncology practice 17 (8), e1094-e1109, 2021 | 26 | 2021 |
| Isolated progression of metastatic lung cancer: Clinical outcomes associated with definitive radiotherapy C Friedes, N Mai, W Fu, C Hu, SZ Hazell, P Han, TR McNutt, PM Forde, ... Cancer 126 (20), 4572-4583, 2020 | 16 | 2020 |
| Cardiac radiation dose is associated with inferior survival but not cardiac events in patients with locally advanced non-small cell lung cancer in the era of immune checkpoint … N Yegya-Raman, SH Lee, C Friedes, X Wang, M Iocolano, TP Kegelman, ... Radiotherapy and Oncology 190, 110005, 2024 | 14 | 2024 |
| The effective radiation dose to immune cells predicts lymphopenia and inferior cancer control in locally advanced NSCLC C Friedes, M Iocolano, SH Lee, L Duan, B Li, A Doucette, RB Cohen, ... Radiotherapy and Oncology 190, 110030, 2024 | 13 | 2024 |
| Late feeding tube dependency in head and neck cancer patients treated with definitive radiation therapy and concurrent systemic therapy C Friedes, J Klingensmith, N Nimo, J Gregor, R Burri Cureus 12 (4), 2020 | 13 | 2020 |
| Consolidative radiotherapy in oligometastatic lung cancer: patient selection with a prediction nomogram C Friedes, N Mai, S Hazell, W Fu, P Han, M Bowers, B Levy, PM Forde, ... Clinical lung cancer 21 (6), e622-e632, 2020 | 11 | 2020 |
| Pneumonitis rates before and after adoption of immunotherapy consolidation in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiation N Yegya-Raman, C Friedes, SH Lee, M Iocolano, L Duan, X Wang, B Li, ... International Journal of Radiation Oncology* Biology* Physics 118 (5), 1445-1454, 2024 | 10 | 2024 |
| Hospitalization and definitive radiotherapy in lung cancer: incidence, risk factors and survival impact SZ Hazell, N Mai, W Fu, C Hu, C Friedes, A Negron, KR Voong, ... BMC cancer 20, 1-10, 2020 | 9 | 2020 |
| Radiologic response of chemotherapy alone versus radiation and chemotherapy in the treatment of locally‐advanced or advanced thymic epithelial tumors RF Chu, A Hussien, QK Li, J Wang, C Friedes, A Ferro, RK Hales, ... Thoracic Cancer 11 (10), 2924-2931, 2020 | 8 | 2020 |
| Patterns of failure, low-volume relapse, and subsequent ablative management in locally advanced non-small cell lung cancer treated with definitive chemoradiation and … C Friedes, M Iocolano, SH Lee, B Li, L Duan, WP Levin, KA Cengel, ... International Journal of Radiation Oncology* Biology* Physics 118 (5), 1435-1444, 2024 | 7 | 2024 |
| Improving early identification of significant weight loss using clinical decision support system in lung cancer radiation therapy P Han, SH Lee, K Noro, JW Haller, M Nakatsugawa, S Sugiyama, ... JCO Clinical Cancer Informatics 5, 944-952, 2021 | 7 | 2021 |
| Exploring the relationship of radiation dose exposed to the length of esophagus and weight loss in patients with lung cancer P Han, R Hales, P Lakshminarayanan, Z Cheng, C Elledge, A Negron, ... Practical radiation oncology 10 (4), 255-264, 2020 | 6 | 2020 |
| Phase 2 trial of consolidation pembrolizumab after proton reirradiation for thoracic recurrences of non-small cell lung cancer N Yegya-Raman, AT Berman, CA Ciunci, C Friedes, E Berlin, M Iocolano, ... International Journal of Radiation Oncology* Biology* Physics 119 (1), 56-65, 2024 | 5 | 2024 |
| Utilization and factors precluding receipt of checkpoint inhibitor consolidation for stage III NSCLC in a large US academic health system N Yegya-Raman, C Friedes, L Sun, M Iocolano, KN Kim, A Doucette, ... Clinical Lung Cancer 24 (5), 474-482, 2023 | 5 | 2023 |
| Incidental periprostatic schwannoma discovered during evaluation for prostatic adenocarcinoma B Dietrick, C Friedes, MJ White, ME Allaf, AR Meyer Urology Case Reports 31, 101150, 2020 | 5 | 2020 |
| Patterns of Failure in Metastatic NSCLC Treated With First Line Pembrolizumab and Use of Local Therapy in Patients With Oligoprogression C Friedes, N Yegya-Raman, S Zhang, M Iocolano, RB Cohen, ... Clinical Lung Cancer 25 (1), 50-60. e6, 2024 | 4 | 2024 |
| Trimodality therapy for esophageal cancer: the role of surgical and radiation treatment parameters in the development of anastomotic complications S Alfaifi, R Chu, X Hui, S Broderick, C Hooker, M Brock, E Bush, R Hales, ... Thoracic Cancer 12 (23), 3121-3129, 2021 | 3 | 2021 |
| Patient-reported outcome measures and dosimetric correlates for early detection of acute radiation therapy–related esophagitis KR Voong, P Han, R Hales, C Hill, C Friedes, T McNutt, S Lee, C Snyder Practical Radiation Oncology 11 (3), 185-192, 2021 | 3 | 2021 |
| Primary ureteral lymphoma presenting as bilateral obstructive uropathy C Friedes, B Dietrick, H Kaur, AR Meyer, JS Winoker Urology Case Reports 33, 101296, 2020 | 3 | 2020 |
steven feigenbergProfessor of Radiation Oncology, University of Pennsylvania在 uphs.upenn.edu 的电子邮件经过验证
